Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction

These findings demonstrated that LXA<sub>4</sub> treatment attenuated the extent of cardiac inflammation in diabetic hearts, resulting in limited cardiac remodeling and improved LV diastolic function. This supports further exploration of LXA<sub>4</sub>-based therapy for the management of diabetic heart disease. The recent development of stable LXA<sub>4</sub> mimetics holds potential as a novel strategy to treat cardiac dysfunction in diabetes, paving the way for innovative and more effective therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology
Published
2024-11-19
DOI
https://doi.org/10.1186/s12933-024-02501-x
Citations
12
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
4.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction

Rebecca H. Ritchie, Cheng Xue Qin, Helen Kiriazis, Eoin Brennan et al.
12 citations
Cardiovascular Diabetology
Cardiovascular Function and Risk Factors
4.82
article

Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction

Rebecca H. Ritchie, Cheng Xue Qin, Helen Kiriazis, Eoin Brennan, Owen L. Woodman, Muthukumar Mohan, Peishen Zhao, Phillip Kantharidis, Mark Emmanuel Cooper, Ting Fu, Cameron J. Nowell, Barbara K. Kemp‐Harper, Madhura Bose, Catherine Godson, Minh Deo
article en
12 citations

Abstract

These findings demonstrated that LXA<sub>4</sub> treatment attenuated the extent of cardiac inflammation in diabetic hearts, resulting in limited cardiac remodeling and improved LV diastolic function. This supports further exploration of LXA<sub>4</sub>-based therapy for the management of diabetic heart disease. The recent development of stable LXA<sub>4</sub> mimetics holds potential as a novel strategy to treat cardiac dysfunction in diabetes, paving the way for innovative and more effective therapeutic strategies.

Cardiovascular DiabetologyVol. 23(1)
University College Dublin (IE), Baker Heart and Diabetes Institute (AU), Discovery Institute (US), Australian Regenerative Medicine Institute (AU), Monash University (AU), University of Pennsylvania (US)
Australian Government, UCD Foundation, Diabetes Australia, National Heart Foundation of Australia, Monash University, State Government of Victoria, Medical Research Council, National Health and Medical Research Council
Good health and well-being
Openalex Percentile: Top 4%
Cardiovascular Function and Risk Factors
4.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.